Cleared Special

K243759 - BIOFIRE Blood Culture Identification 2 (BCID2) Panel (RFIT-ASY-0147 (30 pack) RFIT-ASY-0148 (6 pack)) (FDA 510(k) Clearance)

Dec 2024
Decision
14d
Days
Class 2
Risk

K243759 is an FDA 510(k) clearance for the BIOFIRE Blood Culture Identification 2 (BCID2) Panel (RFIT-ASY-0147 (30 pack) RFIT-ASY-0148 (6 pack)). This device is classified as a Gram-negative Bacteria And Associated Resistance Markers (Class II - Special Controls, product code PEN).

Submitted by Biofire Diagnostics, LLC (Salt Lake City, US). The FDA issued a Cleared decision on December 20, 2024, 14 days after receiving the submission on December 6, 2024.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3365. A Qualitative Multiplexed In Vitro Diagnostic Device To Detect And Identify Gram-negative Bacteria And Resistance Markers In Positive Blood Cultures..

Submission Details

510(k) Number K243759 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 2024
Decision Date December 20, 2024
Days to Decision 14 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PEN — Gram-negative Bacteria And Associated Resistance Markers
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3365
Definition A Qualitative Multiplexed In Vitro Diagnostic Device To Detect And Identify Gram-negative Bacteria And Resistance Markers In Positive Blood Cultures.